Franklin Lakes-based BD (Becton, Dickinson and Co.) on June 8 announced it received pandemic orders for needles and syringes totaling 2 billion injection devices to support global COVID-19 vaccination ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the ...

BD and Ypsomed will expand their collaboration through the development of a 5.5 ml version of BD’s Neopak XtraFlow glass ...

LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...

The new 5.5ml BD Neopak XtraFlow Syringe uses BD’s advanced technologies, including thinner cannulas.

Researchers will highlight new injection systems, wearable devices and testing services supporting high-viscosity biologics, ...

Global Self-Injection Systems Market Trends 2023: This research elaborates on the industrial trends for topmost industries for the insights on Self-Injection Systems market, observes modifications in ...

When BD unveiled a four-year, $1.2 billion upgrade to its drug delivery device manufacturing last year, the company teased plans for a new factory in Europe—and now it’s showing its hand. BD has ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its partnership with Ypsomed to develop a 5.5 mL version of the BD Neopak XtraFlow Glass Prefillable ...

FRANKLIN LAKES, N.J., June 8, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received pandemic orders for ...